Improving the stability of active ingredients through microencapsulation: OSDrC technology and formulation development contract services.
Introducing the localization effect of OSDrC technology! Even active ingredients that become unstable when dispersed can be tabletized.
The "OSDrC" technology, with its variable double-structure core, allows for precise and flexible control of the inner core, enabling the production of higher quality core tablets than ever before, as well as facilitating the development of various new dosage forms. Even active ingredients that become unstable when dispersed can be tabletized into manageable sizes while ensuring stability by localizing the active ingredients within the inner core. 【Features】 ■ Stabilization of active ingredients that become unstable when dispersed is possible ■ Reduction of cross-contamination between the inner core and outer layer is expected ■ Tablets resembling three-layer tablets can be produced by localizing powder in three locations *Data demonstrating the improved stability of active ingredients that become unstable when dispersed due to localization using OSDrC technology can be viewed by downloading from the special website below. *For more details about OSDrC technology, please refer to the OSDrC main brochure available on the special website below, or feel free to contact us.
Inquire About This Product
basic information
Please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
Please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Sanwa Chemical Research Institute, as a member of the Suzuken Group focused on health creation, provides services aimed at improving the quality of life (QOL) for people who wish for better health, centered around its two main businesses: "pharmaceuticals" and "diagnostic drugs." In the "pharmaceuticals business," we are steadily building a track record with a focus on new drugs in the areas of diabetes and kidney/dialysis-related fields. In the "diagnostic drugs business," we are continuously developing and launching self-blood glucose meters, sensors, and diagnostic drugs for infectious diseases. Furthermore, by adding two more businesses— the "OSDrC (Osudrack) business" utilizing innovative formulation technology and the "contract manufacturing business" with advanced quality control systems— Sanwa Chemical Research Institute continues to evolve further.
